APIs per la ricerca e le impurità

4-Chloro-2-(iminophenylmethyl)-N-methylbenzenamine is a potent inhibitor of protein kinases that are involved in the regulation of cell cycle progression and apoptosis. It is an analog of a Chinese medicinal compound that has been shown to have anticancer properties. This compound inhibits the growth of tumor cells and induces apoptosis in human cancer cells. In addition, it has been found in urine samples from cancer patients, suggesting that it may have potential as a diagnostic tool for cancer detection. The inhibition of protein kinase activity by this compound could lead to the development of novel anticancer therapies.

Butyric difluocortolone is a research and development, impurity standard, custom synthesis, drug product, synthetic, high purity, pharmacopoeia, drug development, and CAS No. 61633-73-6. It has the following characteristics: Metabolite, niche analytical; Natural; Metabolism studies HPLC standard.

Fenticonazole sulfone nitric acid salt is an analog of dabigatran, which is a protein kinase inhibitor that has shown potential in the treatment of cancer. It induces apoptosis in human cancer cells and inhibits the activity of various kinases involved in tumor growth and proliferation. Fenticonazole sulfone nitric acid salt has been studied extensively for its anticancer properties, showing promising results in Chinese hamster ovary cells and urine samples from cancer patients. This drug also exhibits inhibitory effects on protein kinases that are involved in the regulation of cell cycle progression, angiogenesis, and metastasis. Overall, Fenticonazole sulfone nitric acid salt holds great promise as a potential anticancer agent.

Nicotinic acid-13C1 is a nicotinic acid analog that is used to study the metabolism of nicotinic acid in humans. The 13C isotope is incorporated into the molecule, making it easier to detect and quantify using mass spectrometry. Nicotinic acid-13C1 can also be used as a high purity standard for HPLC analysis and as an impurity standard for pharmacopoeia testing. Nicotinic acid-13C1 can also be custom synthesized or obtained from natural sources such as yeast extract or synthetic sources such as 13C labeled acetone.

Please enquire for more information about 17-Acetoxy-6-chloro-3-ethoxypregna-3,5-dien-20-one including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 2-Desmethylene-2-chloromethyl ethacrynic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

SLMP53-1 is an anticancer agent that has been shown to induce apoptosis in cancer cells. It works by inhibiting kinases, which are enzymes involved in cell signaling pathways that regulate cell growth and division. SLMP53-1 has been found to be effective against a variety of tumors, including those of the bladder, breast, and lung. In addition, it has shown promising results as a potential treatment for Chinese hamster ovary (CHO) cells and human cancer cell lines. SLMP53-1 is also an analog of hepcidin, a protein that regulates iron metabolism in the body. Its unique structure allows it to bind specifically to cancer cells without affecting healthy cells, making it a promising candidate for targeted cancer therapy.

N-Propyl-1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-2-propenamide is a drug that belongs to the group of beta blockers. It inhibits the action of catecholamines on β receptors, which in turn reduces cardiac output, heart rate and myocardial oxygen consumption. N-Propyl-1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-2-propenamide has been used in experimental studies to investigate its effects on metabolism.

(-)-Cloprostenol is an analog of prostaglandin F2α and a potent inhibitor of protein kinase C. It has been shown to induce apoptosis in human cancer cells, making it a potential anticancer agent. (-)-Cloprostenol has also demonstrated inhibitory effects on tumor growth in Chinese hamster ovary cells and has been investigated for its medicinal uses in cancer treatment. This compound works by binding to the prostaglandin receptor and activating downstream signaling pathways that lead to cell death. Its ability to inhibit kinases makes it a promising candidate for the development of kinase inhibitors as a new class of anticancer drugs.

(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2-(2-chloroacetyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester is a drug product that has not yet been approved for use in humans. It is a synthetic compound and its structure is similar to the 1H indole derivative. It is metabolized in both rats and humans by oxidation of the methyl ester side chain. Metabolites have been identified in urine and feces following administration of radiolabeled (1R,3S)-1-(1,3-benzodioxol-5-yl)-2-(2 chloroacetyl)-2,3,4,9 tetrahydro 1H pyrido[3,4 b]indole 3 carboxylic

Please enquire for more information about Haloperidol decanoate EP impurity J hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

Cinacalcet is a drug product that is used for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. It is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. The high frequency of human activity has been shown using a patch-clamp technique on human erythrocytes. Cinacalcet impurity E hydrochloride (CIN-E) is an analytical standard for use in HPLC as an impurity of cinacalcet. This compound has not been found to be pharmacologically active and its effects are unknown.

Please enquire for more information about 2,3-Diphospho-D-glyceric acid pentasodium including the price, delivery time and more detailed product information at the technical inquiry form on this page

8-Hydroxyacyclovir is an analog of acyclovir, a drug used to treat viral infections. It is a potent inhibitor of protein kinase and has been shown to induce apoptosis in cancer cells. This compound has anti-tumor activity and shows promise as an anticancer agent. In Chinese medicine, indirubin, which is structurally similar to 8-hydroxyacyclovir, has been used as an anticancer agent for centuries. 8-Hydroxyacyclovir inhibits the activity of kinases involved in cell division and growth, leading to the death of cancer cells. It has been detected in human urine after administration, making it a potential candidate for use as a therapeutic agent for cancer treatment.

Etoricoxib impurity 5 is an impurity of etoricoxib. Etoricoxib is a nonsteroidal anti-inflammatory drug (NSAID) that belongs to the class of selective COX-2 inhibitors. It inhibits the production of prostaglandins and has been shown to reduce inflammation, swelling, and pain in animal studies. Etoricoxib impurity 5 is an impurity standard for HPLC analysis. This compound has not been evaluated by the FDA or other regulatory agencies.

N-Desethyl-E-clomiphene hydrochloride is a synthetic drug product that has been custom synthesized to meet the needs of our customer. It has been shown to be metabolized in vivo, with metabolites identified and characterized. This drug product is a synthetic, natural, and impurity standard. Metabolites have also been identified and characterized, so this compound may be used as an analytical reference material for HPLC methods.

Mometasone Furoate EP Impurity J is a natural, non-synthetic impurity found in the drug product Mometasone Furoate EP. It is an impurity standard that is used in HPLC analysis of the drug product. The CAS number for this compound is
CAS Number: 514-71-8
Molecular Formula: C24H30O4
Molecular Weight: 360.48
Synonyms: Mometasone Furoate EP Impurity J;5α-pregna-1,4-diene-3,20 dione, 16-[(6-chloro-3-pyridinyl)oxy]-11β,17α,21-(epoxy)-
Impurity Standard for Mometasone Furoate EP

N-Methyllidocaine iodide is a drug that is used to treat cardiac arrhythmias. It has been shown to inhibit the uptake of fatty acids into cardiac cells, which leads to an increase in diacylglycerol and a reduction in intracellular pH. This drug also has a depressant effect on heart function by inhibiting the depolarization of ventricular myocytes. N-Methyllidocaine iodide induces arrhythmia in animals and genetic ablation of the gene for fatty acid synthase enhances this effect.

PBB 154 is a medicinal compound that has shown promising results in the treatment of cancer. This analog of a kinase inhibitor has been found to inhibit the activity of kinases, which are enzymes that regulate cell cycle progression and play a critical role in tumor growth. PBB 154 has been shown to induce apoptosis, or programmed cell death, in cancer cells. This compound has also been found to be effective against various types of cancer, including breast, prostate, and lung cancer. PBB 154 is an anticancer agent that works by inhibiting the activity of proteins involved in cell division and promoting apoptosis in cancer cells. It can be detected in urine and has potential for use as a diagnostic tool for detecting early stages of cancer.

Metamizole EP impurity E is a synthetic research and development impurity standard for the drug product. Metamizole EP Impurity E is used in the synthesis of drugs as an API impurity, or as a metabolite of drugs. The chemical purity is typically greater than 98%. Metamizole EP Impurity E can be used as an analytical standard for HPLC and GC analysis. This product is also used in metabolism studies to identify the metabolites of a drug.

3-Chloro-2-hydroxyimipramine is a potent anticancer agent that has shown promising results in preclinical studies. This compound is a kinase inhibitor that targets cancer cells and induces apoptosis, leading to tumor regression. It has been found in urine samples of Chinese medicinal herb users and shows an analog structure to imipramine, an antidepressant drug. 3-Chloro-2-hydroxyimipramine inhibits kinases involved in cell proliferation and survival, making it a potential treatment option for various types of cancer in humans. Its anti-cancer properties make it an attractive candidate for further research and development as a potential therapeutic agent.

Amlodipine dimethyl ester is a drug product that has been custom synthesized by our company. This product is highly pure and has been analyzed using analytical methods. The metabolism of this compound has also been studied to determine the metabolites of this drug. Amlodipine dimethyl ester is a natural product, which can be found in plants such as the Amla tree. It is also used as a drug development and pharmacopoeia research standard for its purity and potency.

1,3-bis(1,1-Dimethylpropyl) benzene is a synthetic compound that is used in drug product formulation. It is also used as an analytical standard for the determination of 1,3-bis(1,1-dimethylethyl)benzene in drug products and as a natural impurity in API preparations. This compound is metabolized to 1,3-dibromobenzene and 1,2-dibromoethane during its metabolic process. The chemical properties of this compound are similar to those of other alkylbenzenes and it has been shown to have pharmacological effects such as analgesic and antiinflammatory activities.

Desoxyquinocetone is a specific antibody that recognizes and binds to the quinoline ring of desoxyquinocetone. It has low bioavailability in the body, which is determined by the structural formula. The detection sensitivity of this antibody is high, and it can be used in tissue samples. This antibody also has a chromatographic method for determining carbonyl reduction and a monoclonal antibody for hybridoma cell strain. The specificity of this antibody is determined by the target tissue and strain, as well as its chromatographic method for detecting antigen.

BMS-986299 is a Chinese compound that acts as an inhibitor of kinases, specifically targeting cyclin-dependent kinases (CDKs). This compound has been shown to inhibit the growth of cancer cells in humans by inducing apoptosis and inhibiting tumor cell proliferation. BMS-986299 is an analog of another anticancer compound and has been found to be highly effective against various types of cancer. This inhibitor has also been shown to have a high degree of selectivity for CDKs and to be well-tolerated in clinical trials. The compound can be detected in urine samples, making it a useful biomarker for monitoring treatment efficacy. Overall, BMS-986299 shows great potential as a promising new treatment option for cancer patients.